Table 5.
Test | Ratio | p-value (against day 0) | Neg → pos (%neg) | Pos → neg (%pos) | Difference of prevalence (%) |
---|---|---|---|---|---|
S1-specific IgG | 1.56 | 0.212 | 2.0 | 55.2 | 0.7 |
S1-specific IgA | 0.33 | <0.001 | 2.6 | 70.8 | −4.8 |
RBD-specific IgM | 2.88 | 0.012 | 1.8 | 53.3 | 1.2 |
RBD-specific total antibodies | >54 | <0.001 | 2.1 | 0.0 | 2.1 |
NCP-specific IgG | 3.00 | 0.014 | 1.6 | 50.0 | 1.1 |
Changes are indicated by the ratio of newly positives to those that became negative; and the proportion of negatives that became positive (neg → pos) as well as the proportion of positives that became negative (pos → neg) and difference of prevalences of positives at month 6 and day 0; p-value assessed by Chi² McNemar. S1 subunit of spike protein (S1), receptor-binding domain (RBD), nucleocapsid (NCP).